Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Derivatives -- Ignore unavailable to you. Want to Upgrade?

To: LLCF who wrote (62)	3/30/1999 5:18:00 PM
From: LLCF	Respond to of 555

<Morgan Stanley sold 2000 ALKS April 30 calls, Wonder what he knows?> Well, wadda ya know, a little stock for sale. Wonder if ole Morgan is making part of the bid! ha ha ha... what scum: "Alza Corp. the No. 1 U.S. maker of controlled-release drugs, said it will sell some or all of its 8 percent stake in ALKS as the smaller drug-delivery company's shares trade near their all-time high." Bloomberg The release goes on to say that they paid $25 shr for 'em in Feb 1997. They will sell the shares in the open market from time to time. Info was released in their 13D apparently. DAK